Skip to content

Perfusion Index Changes in Cardiovascular Autonom Neuropathia Type-2 Dm Whit Spinal Anesthesia

Observational Study Relationship Between Perfusion Index Changes and Intraoperative Complications in Cardiovascular Autonom Neuropathia Type-2 DM Patients With Spinal Anesthesia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03869775
Acronym
PI
Enrollment
240
Registered
2019-03-11
Start date
2017-12-01
Completion date
2020-12-01
Last updated
2019-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia; Adverse Effect

Brief summary

Cardiovascular autonomic neuropathy in diabetic patients, hypertension, sympathovagal imbalance, orthostatic hypotension, painless myocardial infarction, ischemia, left ventricular dysfunction, cardiac sympathetic and parasympathetic innervation disturbances, qt interval prolongation and sudden deaths observed. The purpose of this study is to evaluate the relationship between cardiovascular autonomic neuropathy and perfusion index in spinal anesthesia

Detailed description

Cardiovascular autonomic neuropathy in diabetic patients, hypertension, sympathovagal imbalance, orthostatic hypotension, painless myocardial infarction, ischemia, left ventricular dysfunction, cardiac sympathetic and parasympathetic innervation disturbances, qt interval prolongation and sudden deaths observed. The purpose of this study is to evaluate the relationship between cardiovascular autonomic neuropathy and perfusion index in spinal anesthesia

Interventions

DEVICEperfusion index monitor

perfusion index measured in patients undergoing spinal anesthesia with non-invasive perfusion index monitor

DIAGNOSTIC_TESTewing test

ewing tests will be applied to diabetic patients undergoing spinal anesthesia for cardıovascular autonomous neuropathıa diagnosis

Sponsors

Erzincan University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* the patient will be operated with spinal anesthesia * over 18 years * no additional disease and only DM

Exclusion criteria

* patients with additional disease * patients under 18 years of age * patients contraindicated in spinal anesthesia

Design outcomes

Primary

MeasureTime frameDescription
Perfusion index changeDay 1Perfusion index change in spinal anesthesia related cardiovascular autonom neuropatia

Countries

Turkey (Türkiye)

Contacts

Primary ContactFARUK SUBAŞI
dr.faruksubasi@gmail.com5414247924

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026